+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneus Ltd - logo

Founded in 2007, Regeneus are a Sydney-based regenerative medicine company developing a portfolio of innovative cell-based therapies, with a focus on osteoarthritis and musculoskeletal disorders, as well as oncology and dermatology diseases. The company's portfolio of therapeutic products is being developed using stem cell and immune oncology technology platforms.The company has two product candidates in Phase 1 trials for humans, Progenza and RGSH4K. Regeneus is headquartered in New South Wales, Australia.

Wounds (Dermatology) - Drugs in Development, 2021 - Product Thumbnail Image

Wounds (Dermatology) - Drugs in Development, 2021

  • Report
  • November 2021
  • 274 Pages
From
From
Cell Therapy Biomanufacturing: Global Markets - Product Thumbnail Image

Cell Therapy Biomanufacturing: Global Markets

  • Report
  • February 2021
  • 112 Pages
From
Psoriasis (Immunology) - Drugs In Development, 2021 - Product Thumbnail Image

Psoriasis (Immunology) - Drugs In Development, 2021

  • Report
  • July 2021
  • 1178 Pages
From
Radiodermatitis - Drugs in Development, 2021 - Product Thumbnail Image

Radiodermatitis - Drugs in Development, 2021

  • Report
  • November 2021
  • 73 Pages
From
From
From
From
From
From
From
From
Burns (Dermatology) - Drugs In Development, 2021 - Product Thumbnail Image

Burns (Dermatology) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 142 Pages
From
Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2020 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 684 Pages
From
Loading Indicator